» Articles » PMID: 25143913

Vitamin D Levels and Microvascular Complications in Type 2 Diabetes

Overview
Specialty Endocrinology
Date 2014 Aug 22
PMID 25143913
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D has important actions on glucose metabolism. These include improved insulin exocytosis, direct stimulation of insulin receptor, improved uptake of glucose by peripheral tissues, improving insulin resistance. It has got various pleiotropic effects like suppression of cell mediated immunity, regulation of cell proliferation, stimulation of neurotropic factors such as nerve growth factor, Glial cell line-derived neurotrophic factor, neurotropin, suppression of RAAS, reduction of albuminuria, immunomodulatory effects, and anti-inflammatory effects. Thus, vitamin D is implicated in many ways in the pathogenesis of retinopathy, neuropathy and nephropathy.

Objectives: To study the correlation of vitamin D levels with microvascular complications in type 2 diabetes.

Materials And Methods: Cross-sectional case-control study of 18 patients (18-70 years), who met the American Diabetes Association 2011 criteria for type 2 diabetes, was conducted. Age and sex matched healthy controls were taken. Subjects were evaluated for the presence of microvascular complications by clinical evaluation, urine examination, fundus examination, nerve conduction studies, and various biochemical tests. 25-OH cholecalciferol levels were done for each. Cut off level for vitamin D deficiency was 20 ng/ml.

Results: Mean vitamin D was lower in type 2 diabetics than healthy subjects (19.046 vs. 27.186 ng/ml). Prevalence of vitamin D deficiency and insufficiency was found to significantly higher in diabetics when compared to healthy subjects (P = 0.0001). Vitamin D deficiency was found to be significantly associated with neuropathy (χ(2) = 5.39, df = 1, P = 0.020), retinopathy, (χ(2) = 6.6, df = 1, P = 0.010) and nephropathy (χ(2) = 10. 52, df = 1, P = 0.001). Lower levels of vitamin D were found to be associated with increasing prevalence of combinations of microvascular complications namely neuropathy with retinopathy (P = 0.036), neuropathy with nephropathy (P = 0.029), retinopathy with nephropathy (P = 0.022) and neuropathy with retinopathy with nephropathy (P = 0.0001).

Citing Articles

Association between serum vitamin D and the risk of diabetic kidney disease in patients with type 2 diabetes.

Wang Y, Hu C, Li Y, Liu Q, Gao L, Zhang D Front Med (Lausanne). 2024; 11:1445487.

PMID: 39185464 PMC: 11342449. DOI: 10.3389/fmed.2024.1445487.


Novel Insight Into the Relationship of Vitamin D Hydroxylase and Vitamin D With Obesity in Patients With Type 2 Diabetes Mellitus.

Bakhuraysah M, Gharib A, Hassan A, Al Harthi G, Al Thobaiti R, Al Adwani M Cureus. 2024; 15(12):e49950.

PMID: 38179344 PMC: 10765456. DOI: 10.7759/cureus.49950.


The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art.

Argano C, Mirarchi L, Amodeo S, Orlando V, Torres A, Corrao S Int J Mol Sci. 2023; 24(20).

PMID: 37895163 PMC: 10607188. DOI: 10.3390/ijms242015485.


Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients.

Dean Y, Elawady S, Shi W, Salem A, Chotwatanapong A, Ashraf H Endocrinol Diabetes Metab. 2023; 6(6):e453.

PMID: 37743677 PMC: 10638614. DOI: 10.1002/edm2.453.


The Impact of Vitamin D Deficiency and Insufficiency on the Outcome of Type 2 Diabetes Mellitus Patients: A Systematic Review.

Md Isa Z, Amsah N, Ahmad N Nutrients. 2023; 15(10).

PMID: 37242192 PMC: 10223393. DOI: 10.3390/nu15102310.


References
1.
Kim M, Frankel A, Donaldson M, Darch S, Pusey C, Hill P . Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int. 2011; 80(8):851-60. DOI: 10.1038/ki.2011.224. View

2.
Vidotti D, Casarini D, Cristovam P, Leite C, Schor N, Boim M . High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol. 2004; 286(6):F1039-45. DOI: 10.1152/ajprenal.00371.2003. View

3.
Zhang Y, Deb D, Kong J, Ning G, Wang Y, Li G . Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009; 297(3):F791-801. PMC: 2739712. DOI: 10.1152/ajprenal.00247.2009. View

4.
Taverna M, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Slama G . Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia. 2002; 45(3):436-42. DOI: 10.1007/s00125-001-0769-2. View

5.
Diaz V, Mainous 3rd A, Carek P, Wessell A, Everett C . The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med. 2009; 22(5):521-7. DOI: 10.3122/jabfm.2009.05.080231. View